Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalit...
Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities
EUPHORIA will pave the way to establish MSOT (Multispectral Optoacoustic Tomography) technology for the non-invasive assessment of intestinal inflammation in patients. EUPHORIA will enable commercialization of the technology by fi...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
FRONTIER
From Research Optoacoustic Novelty To Imaging Established in...
4M€
Cerrado
IseeG
FunctIonal optoacousticS for imaging Early onsEt of Gut infl...
1M€
Cerrado
IACOBUS
Diagnosis and Monitoring of Inflammatory and Arthritic disea...
4M€
Cerrado
PREMSOT
Precision Multi Spectral Optoacoustic Tomography for Discove...
2M€
Cerrado
EMSOT
Endoscopic Multi Spectral Optoacoustic Tomography
165K€
Cerrado
Duración del proyecto: 42 meses
Fecha Inicio: 2018-12-14
Fecha Fin: 2022-06-30
Líder del proyecto
ITHERA MEDICAL GMBH
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
3M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
EUPHORIA will pave the way to establish MSOT (Multispectral Optoacoustic Tomography) technology for the non-invasive assessment of intestinal inflammation in patients. EUPHORIA will enable commercialization of the technology by finalizing technical improvements that will increase diagnostic outcome beyond what has been shown in a first feasibility study, will improve usability, prepare CE marking for the new device and validate clinical results in a large clinical study.
Inflammatory bowel disease (IBD) is a chronic condition, posing significant burden to patients and health care systems. Patients suffer from a relapsing course of intestinal inflammation, and to date, there is no satisfying non-invasive diagnostic modality for monitoring disease activity. In a recent clinical study conducted by University Hospital Erlangen, MSOT, a technology developed by iThera Medical (ITM), has proven to be superior in diagnostic performance to other procedures.
Imasonic (IMA) and RayFos (RFO) are ideally positioned to drive the technical improvement steps: Imasonic, an expert in ultrasound transducer manufacturing, will develop an ultrasound detector with higher signal-to-noise ratio to enable better sensitivity and detection at depth. RayFos specializes on real-time sensing and image inversion, processing and rendering and has significant experience in optoacoustic tomography algorithms and implementation. iThera Medical will lead the incorporation into the device, CE marking and commercialization. The University Hospital Erlangen is an excellence center in IBD and will drive the clinical validation. Pintail has extensive project management, dissemination and commercialization expertise.